← Eichor
Study identifier: NCT06439225 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Platinum and Taxane Chemo in Met Castration Resistant Prostate Cancer Patients With Alterations in DNA Damage Response Genes

Condition: Metastatic Castration-resistant Prostate Cancer · Metastatic Prostate Cancer  ·  Sponsor: Canadian Cancer Trials Group

PhasePhase 3
Planned participants236
Who can joinMale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The usual approach for most patients who are not in a study is treatment with docetaxel. This study is being done to answer the following question: Can the chance of prostate cancer growing or spreading be lowered by adding a drug to the usual approach? This study is being done to find out if this approach is better or worse than the usual approach for prostate cancer. The usual approach is defined as the care most people get for prostate cancer.

This description comes directly from the study's public registry record.

Talk to the study team

Mariam Jafri  ·  613-533-6430  ·  mjafri@ctg.queensu.ca

Wendy Parulekar  ·  613-533-6430  ·  wparulekar@ctg.queensu.ca

Always discuss trial participation with your own doctor first.

Locations (14)

Arthur J.E. Child Comprehensive Cancer CentreCalgary, Alberta, CanadaRecruiting
Cross Cancer InstituteEdmonton, Alberta, CanadaRecruiting
BCCA - VancouverVancouver, British Columbia, CanadaRecruiting
William Osler Health SystemBrampton, Ontario, CanadaRecruiting
Waterloo Regional Health Network (WRHN)Kitchener, Ontario, CanadaRecruiting
London Health Sciences Centre Research Inc.London, Ontario, CanadaRecruiting
Ottawa Hospital Research InstituteOttawa, Ontario, CanadaRecruiting
Odette Cancer CentreToronto, Ontario, CanadaRecruiting
University Health NetworkToronto, Ontario, CanadaRecruiting
CHUM-Centre Hospitalier de l'Universite de MontrealMontreal, Quebec, CanadaRecruiting
The Jewish General HospitalMontreal, Quebec, CanadaRecruiting
CHU de Quebec-Hopital l'Enfant-Jesus (HEJ)Québec, Quebec, CanadaRecruiting

+ 2 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06439225